Vivos (RDGL) EBITDA Margin (QoQ) (2011 - 2025)
Vivos (RDGL) EBITDA Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -127,008.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 361,365.00 |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | 895,613.00 |
| Sep 30, 2023 | 424,444.00 |
| Jun 30, 2023 | -992,914.00 |
| Mar 31, 2023 | 671,924.00 |
| Dec 31, 2022 | -659,533.00 |
| Sep 30, 2022 | 323,782.00 |
| Jun 30, 2022 | -175,042.00 |
| Dec 31, 2019 | -1.40 Mn |
| Sep 30, 2016 | 6.30 Mn |
| Jun 30, 2016 | -6.26 Mn |
| Jun 30, 2014 | -140,945.00 |
| Mar 31, 2013 | -374,095.00 |
| Dec 31, 2012 | 120,588.00 |
| Sep 30, 2012 | 0.00 |